The steady generic pricing is a tailwind and execution of key launches like gAbraxane for Cipla will determine the path of US sales in 2025.
Jupiter Wagons shares rally 8% on Rs 1,140 crore Railway Board order
Jupiter Wagons shares rallied over 8% after securing a Rs 1,140 crore Railway Board order for 2,583 wagons. The company expects additional order inflows of